Target intelligence / Profile preview

No direct biological target

Molecular classification
Other
01

Overview

The designation "No direct biological target" is used in pharmacology and drug databases to classify therapeutic agents that do not exert their primary effect by binding to a specific biological macromolecule, such as a receptor, enzyme, or ion channel (Goodman & Gilman's The Pharmacological Basis of Therapeutics). Instead, these agents function through non-specific physical or chemical mechanisms. For instance, antacids like calcium carbonate neutralize gastric acid via a direct chemical reaction, while osmotic laxatives like polyethylene glycol work by creating a physical osmotic gradient that retains water in the intestinal lumen (FDA Label: MiraLAX). Other examples include activated charcoal, which acts as an adsorbent to physically trap toxins in the gastrointestinal tract, and simethicone, which alters the surface tension of gas bubbles (PubChem). This classification is essential for distinguishing non-targeted therapies from those that rely on high-affinity protein-ligand interactions. Because these agents lack a specific protein target, they are generally not subject to the same types of mutational resistance seen in targeted molecular therapies (ChEMBL Database).

Other names
Non-specific mechanismPhysical/Chemical actionNon-protein targetUnassigned target
02

Mechanism of action

Physical or chemical interaction including acid neutralization, osmotic gradient modification, physical adsorption, or surface tension alteration.

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Electrolyte imbalanceInterference with the absorption of co-administered drugsDehydrationSystemic pH alterations
06

Interacting drugs

Magnesium hydroxide

5 more in the full profile.

07

Biomarkers

Gastric pHSerum electrolyte levelsUrine osmolality

Beyond the preview

Go deeper on No direct biological target.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on No direct biological target.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call